ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Anavex Life Sciences Corporation

Anavex Life Sciences Corporation (AVXL)

3.68
-0.10
(-2.65%)
Closed April 22 4:00PM
3.69
0.01
(0.27%)
After Hours: 7:02PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.69
Bid
3.68
Ask
3.97
Volume
1,358,524
3.64 Day's Range 3.85
3.60 52 Week Range 10.45
Market Cap
Previous Close
3.78
Open
3.85
Last Trade
1
@
3.73
Last Trade Time
Financial Volume
$ 5,093,966
VWAP
3.7496
Average Volume (3m)
1,305,830
Shares Outstanding
82,112,511
Dividend Yield
-
PE Ratio
-6.36
Earnings Per Share (EPS)
-0.58
Revenue
-
Net Profit
-47.51M

About Anavex Life Sciences Corporation

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are u... Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Carson City, Nevada, USA
Founded
1970
Anavex Life Sciences Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker AVXL. The last closing price for Anavex Life Sciences was $3.78. Over the last year, Anavex Life Sciences shares have traded in a share price range of $ 3.60 to $ 10.45.

Anavex Life Sciences currently has 82,112,511 shares outstanding. The market capitalization of Anavex Life Sciences is $302.17 million. Anavex Life Sciences has a price to earnings ratio (PE ratio) of -6.36.

AVXL Latest News

Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)

Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) PR Newswire NEW YORK, April 19, 2024 NEW YORK, April 19, 2024 /PRNewswire/...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL PR Newswire NEW YORK, April 16, 2024 NEW YORK, April 16, 2024...

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, April 12, 2024 NEW YORK, April 12, 2024...

Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm PR Newswire NEW YORK, April 9, 2024 NEW YORK, April 9, 2024...

Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL

Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024...

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL

Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL PR Newswire NEW YORK, April 2, 2024 NEW YORK, April 2...

Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PR Newswire NEW YORK, March 29, 2024 NEW YORK, March 29, 2024...

Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL

Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL PR Newswire NEW YORK, March 26, 2024 NEW YORK, March 26...

Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.62-14.38515081214.314.36443.614837583.96000423CS
4-0.97-20.81545064384.665.23.612218564.38531966CS
12-2.65-41.79810725556.346.8193.613058305.04428896CS
26-1.48-28.62669245655.1710.453.613616686.11204593CS
52-4.32-53.93258426978.0110.453.611176036.90302306CS
156-8.39-69.453642384112.0831.53.6126614212.21376705CS
2600.7826.80412371132.9131.52.2124039410.62877117CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MTTRMatterport Inc
$ 4.785
(175.00%)
72.29M
AGBAAGBA Group Holding Ltd
$ 2.52
(101.60%)
211.82M
MLECMoolec Science SA
$ 2.443
(74.50%)
79.68M
NIVFNewGenIvf Group Ltd
$ 1.30
(68.83%)
80.49M
EDBLEdible Garden AG Inc
$ 6.26
(66.49%)
16.04M
VAXXVaxxinity Inc
$ 0.2636
(-44.63%)
5.86M
IKTInhibikase Therapeutics Inc
$ 1.37
(-32.84%)
369.21k
TWGTop Wealth Group Holding Ltd
$ 2.55
(-31.64%)
2.56M
BPTHBio Path Holdings Inc
$ 2.96
(-31.00%)
869.47k
TELOTelomir Pharmaceuticals Inc
$ 5.6001
(-29.87%)
134.23k
AGBAAGBA Group Holding Ltd
$ 2.52
(101.60%)
211.85M
SQQQProShares UltraPro Short QQQ
$ 12.47
(-2.88%)
157.15M
TSLATesla Inc
$ 142.05
(-3.40%)
107.15M
JAGXJaguar Health Inc
$ 0.1798
(14.60%)
106.88M
NIVFNewGenIvf Group Ltd
$ 1.30
(68.83%)
80.5M

AVXL Discussion

View Posts
ignatiusrielly35 ignatiusrielly35 3 minutes ago
Uh oh. Looks like someone’s handler fed him some TA nonsense to regurgitate.
👍️0
XenaLives XenaLives 7 minutes ago
BLAH BLAH BLAH....

The 2021 peak was a function of the market as a whole.

Many good companies were subjected to pump and dump AI manipulation during the same period.

For that reason your scenario is meaningless.
🎯 1 👍️ 1
tootalljones tootalljones 30 minutes ago
some relevant technical stock analysis, the 5 year chart is of paramount importance. Most technicians prefer the 5 year chart over the 8 and 11 year, *(and even the 146 monthlys) charts that some others tend to favor.
The 5 year shows about 2 years of range bound price action from 3.30 to about 5.56.
then it broke out of this range and exploded in january 2021 in two tremendous bursts, from 6 to 15 bucks, and after a retracement, from 12 to 30 bucks.
Then, the 5 year chart shows an immediate retrenchment from 30 to roughly 19, and then after consolidating, the chart shows it went furiously from 19 to 12 bucks even.
Then, the 5 year shows that in early 2023, it broke out of its consolidation and moved from 12 to 8, a huge move.
The 5 year chart then shows a very fast powerful burst (which George and Bas both predicted btw), from 5.25 to 9.90, an incredible power explosion higher which occurred in the last couple months of last year, 2023.
Then, there was a "topping pattern" at the apex of the great 2023 surge, but like gravity, she was pulled down in feb 2024 to 6 bucks even
At Six bucks ($6.), she consolidated briefly and the last couple months, of 2024, she began a huge power move down to break $4 dollars in a tremendous impressive surge (predicted by George), to its current price of $3.69, which reverse split adjustment, and looking at 146 monthly chart, you can see that it is actually back to 90 cents.
For those of us who were in and profited back then, there is little support now except the good old .60 cent breakout move, which occurred in 2015.....This is reverse split adjusted now to a price of $2.40 cents, where support should hold for at least 4 months. If she should fail us then, we are looking at an impulse move back to the old 22 cent mark, which will mean a price of $.84 cents....
Some say it will never go that low, but you never know. There is no clear pattern in the 5 year chart at all..
🆖 1 👎️ 1 💩 2
Talon38 Talon38 36 minutes ago
Bill....you are so right about Leqembi(and you spelled it right). It is certainly not been the blockbuster that Biogen/Eisai had anticipated. The plaque crowd has been letdown by the FDA and EMA. As I have pointed out in earlier posts, Biogen and Anavex have been going around since aducanumab and 2-73 went at each other(for Alzheimer's) in Anavex's MS evaluation in Biogen's lab years ago!

Talon
🆖 1 👍️ 1 💩 1
jav0033 jav0033 39 minutes ago
Missling is a proven LIAR and a CROOK that has extorted Shareholders for last 10
Years.

He lies finally were uncovered and this
Company is headed to $1.249
👎️ 2 💩 2 🤡 1
BIOChecker4 BIOChecker4 2 hours ago
“Credibility matters.”

And how.

Credibility and reputation, two things totally lacking at Anavex. Missling could be a genius and it wouldn’t matter. He’s proven himself to be a total liability. Investors don’t take him seriously. Neither does big pharma. The stock price tells us everything we need to know.

Missling is not indispensable. He can and should be replaced. It’s time!
🎯 2 🏆️ 1 👍️ 1 👎️ 2 💩 2
ChrisMissing ChrisMissing 2 hours ago
They have already hired someone for this.

http://linkedin.com/in/david-goldberger-2439a14

He has all the EMA experience, knowledge and contacts Look at his role with Otsuka. He knows how to get this done.
🆖 2 🎯 2 👍️ 5 💩 1
sumbuysumsell sumbuysumsell 2 hours ago
Question - What happens when the market does not believe it when a CEO says they are in dialogue to submit an MAA to the EMA?
Answer - The share price drops precipitously to trade at multiple year lows.
Credibility matters.
🎯 1 🏆️ 1 👍️ 2 👎️ 1 💩 1
skitahoe skitahoe 3 hours ago
I have no knowledge of Anavex's capabilities, but I know that NWBO used a contractor who specializes in regulatory submission to do the submission to the UK. I believe it's done electronically and doubt if many pages are actually printed at all.

I would suspect the company will seek out a specialist when they're ready, I know in NWBO's case it took longer than anticipated, and I suspect that either the specialist, or regulator itself, wanted changes prior to finalizing the submission. Such things are generally not discussed by most companies, and frankly NWBO made a mistake by providing an estimated time, then delaying it twice. It would have been smarter to forecast roughly the quarter and erred on the side of caution if they thought it would be in the last month of the quarter. Filing early would be great, but issuing guidance delaying the filing is a big negative, and NWBO did that twice.

Gary
🆖 1 👍️ 3 💩 1
poguemahone poguemahone 3 hours ago
Kund is correct again. Some quick math—take $3.68 and divide by 4. Or in Falconeer speak, take the dividend of $3.68 and divide by the divisor of 4, and your quotient is 92 cents.

Think about that for a moment—92 cents R/S share. This SP for 9 years of CNS drug “development” gets 99.9% of CEOs fired. We’re the .1% reason it’s not 100%.

Thank you to our useless BOD, who have done nothing other than disregard their fiduciary responsibility to its shareholders.

Bring on the lawsuits—this is inexcusable and disgraceful.
🆖 1 👍️ 3 👎️ 2 💩 4 🤡 1
kund kund 3 hours ago
Missing did not dilute like a typical biotechnology. Only 80 million shares outstanding Another Misleading apologist. In 2015 he R/S from 100mil to 25mil and now we are back to 80mil, but he didn't dilute.
👍️ 3 👎️ 1 💩 1
nidan7500 nidan7500 3 hours ago
A helpful, well informed assessment. Thanks.our CEO is playing by the pre-submission rules of the EMA, which he must.
so far we can safely say that he has given the EMA a projected filing date for the MAA in calendar Q3 of this year
Danke.
🆖 1 👍️ 2 💩 1
Lacey1 Lacey1 4 hours ago
This bleeding down is the hedge funds who have almost no shares, pushing the price down to free up shares from impatient retail. Missing did not dilute like a typical biotechnology. Only 80 million shares outstanding. And this for a company that has the best drug the Neuro industry has ever seen. 43 shorts on this board.
🆖 1 🍼 1 👍️ 12 👏 1 💥 2
WilliamMunny WilliamMunny 4 hours ago
plexrec, our CEO is playing by the pre-submission rules of the EMA, which he must. There are certain timing requirements that has to abide by. You can look it up, as Casey Stengel used to say. From what we have seen of the process so far we can safely say that he has given the EMA a projected filing date for the MAA in calendar Q3 of this year (and more likely in the first month or two).
🆖 1 🎯 1 👍️ 5 💩 1
WilliamMunny WilliamMunny 4 hours ago
Actually, Talon, Biogen is holding below $200 because of - not despite - Leqembi. The drug is falling well below sales projections. There are a variety of reasons, of course: physicians are, not surprisingly, quite leery about the possible side effects from a drug that is the first one with a black-box warning to be granted full approval by the FDA in two decades; infusion center capacities also seem to be a problem; getting PET scans signed off by private Medicare Advantage plans is another issue; approval by the EMA has been held up for further review, since the previously cited issues would seem to be even more of a problem in Europe; and Biogen/Eisai have been forced to delay an application for an injectable version after the FDA asked for several more months of immune response data. So, yes, Leqembi is doing no favors for BIIB shareholders.
🎯 1 🏆️ 1 👍️ 5
plexrec plexrec 4 hours ago
Bourbon--" until an NDA is filed with the EMA"---so what's with not filing already---what is our CEO waiting for ??????.
🎯 1 🏆️ 1
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 4 hours ago
NO reason to touch AVXL until an NDA is filed with the EMA.

Until then this will just melt downward due to total lack of interest.
🎯 1 🏆️ 1 👍️ 3
123tom 123tom 4 hours ago
Price needs a bullish bounce tomorrow, right now and needs to climb to reach 4.00 to begin recovery from a 3.60 low. If 3.60 were to hold as a cycle low.
Tomorrow, watch the open and first 2 hours, for any continued tumble down to test 3.60 and break lower. Target steps bleed to 3 dollars if it falls. The bleeding down game continues until the bottom zone is reached and until good news comes. Which could include lawsuit dismissal.
But for tomorrow... watch to see if 3.60 is retested, then 3.70 fails and price tumbles down through the week, to the lower targets. Everyone here is just posting emotional venting and bickering, completely useless, while the wall street trading computers keep generating the bleeding down game. Find your buy targets, find your put targets. Watch the price action and get away from useless venting. Trade like a professional. Watch the price action and chart patterns of support and resistance steps, have a plan to execute when your targets arrive. Make changes and adjustments along the way as the dynamic price action gives clues. Tomorrow will give some more clues. Everybody stop bitching and bickering. Y'all sound like amateurs and noobies.
🆖 1 👍️ 2 💤 1 💩 3
Thehubby Thehubby 4 hours ago
It pains me to say....
It is becoming clearer by the day that Missling can't deliver the mail ...under $3.70 share is all that needs be said
🎯 1 🏆️ 1 👍️ 3 👎️ 1 💩 3
jav0033 jav0033 4 hours ago
Please, Missling is a Lying SON OF A BITCH!!!
👎️ 1 💩 2
jav0033 jav0033 4 hours ago
$1.249 CLUB HERE WE GO!!!

WE GOT THIS!!!

THE GOOD DOCTOR!!

4D CHESS MASTER!!
👍️ 1 👎️ 1 💩 2
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 4 hours ago
What we have here is a failure to execute
🎯 1 🏆️ 1 👍️ 1 👎️ 2 💩 2
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 4 hours ago
WGSHIT
🌋 1 🎯 1 🎲 1 👎️ 1 💩 3
go avxl go avxl 4 hours ago
WGT= We Got TBSD

ALL BUTT SHIIIIIT

SHOW ME NDA FIRST
🌋 1 🎯 1 🏆️ 1 👍️ 3 👎️ 1 💩 1
BIOChecker4 BIOChecker4 5 hours ago
Still no date for annual meeting? Hmmm… that’s weird. Maybe Missling and the BOD are negotiating the termination of his contract and the BOD wants to announce a new CEO before holding the annual meeting.

One can only hope…
🎯 1 🏆️ 1 👍️ 2 👎️ 2 💩 2 🤡 1
attilathehunt attilathehunt 5 hours ago
very much looking at what is going on because you are ready to jump right back in


Not likely....waiting for a bounce to 4.25 in order to buy puts would be more like it...So guess I should be pumping...Com'n Chris release the full PD data...You can do it....Maybe surprise us with the mystery rare disease trial...You can do it...maybe the AD results...You can do it....But please, no more conferences...


I was a happy long and then a frustrated long for over 9 years so I like to stick around with the hopes the BOD come to their senses and fire Chris.


By the way, I believe the lead plaintiff was long at least 40k shares.
🍼 1 🏧 1 👎️ 1 💩 1
BIOChecker4 BIOChecker4 5 hours ago
Remember when our favorite pumper said Anavex is one of the world’s greatest companies and Missling is one of the world’s greatest CEOs?

How’s that working out? Hahahaha!

This is dead money for the foreseeable future. It appears nobody is excited except short sellers and delusional anti-vaxxers.
🎯 1 🏆️ 1 👍️ 1 👎️ 1 💩 1 🤡 1
Cpap21 Cpap21 5 hours ago
You are telling us everything we already know . If you sold and think you out smarted us, then good for you, but the truth is that you are very much looking at what is going on because you are ready to jump right back in .Finger on the trigger !!
If you were truly done with this stock you would be gone to your next big winner.
And misery is always looking for company !!!
🎯 2 🏆️ 1 👍️ 1
sage4 sage4 5 hours ago
He/she got so excited coz he/she got his/her predictions right for the first time.
I don't blame him/her. - -
🆖 1 💩 1
attilathehunt attilathehunt 5 hours ago
he need money to go on vacation with model


Oh brother...It's the model's brother he is interested in. You haven't figured that out by now?
👎️ 1 💩 2
Talon38 Talon38 5 hours ago
Biogen is holding below $200 ($194) despite Lequembi. They and their big institutional investor, BlackRock, are using their MM/Shorts to keep AVXL at bay. Those who say there is no manipulation have not counted the "dollars" in the WW Alzheimers market!
🎯 4 🏆️ 4 👍️ 10 💥 1 ❤️ 2
attilathehunt attilathehunt 5 hours ago
LOL!!!

Put me on ignore if you despise the truth...
🆖 1 🍼 1 👎️ 1 💩 2
Reyeton Reyeton 7 hours ago
Why doesn’t he just submit the dang disc? Problem solved. Printing is so outdated anyway. Save the trees. Rett failed. Now I’m beginning to wonder if it works for AD. If it stops brain shrinkage, that’s a good start. Maybe it needs to chaperone with another molecule. Come on Missling, people are suffering.
👍️ 1
Thehubby Thehubby 7 hours ago
Life too short...they are my second ignore..George being the first
🎯 1 🏆️ 1 👎️ 1 💩 1
kund kund 7 hours ago
bas2020 hope you are deploying your dry powder, Misleading need to cash his options, he need money to go on vacation with model and think about how to print millions and millions of pages.
👎️ 1 💩 2 💰️ 1
Cpap21 Cpap21 8 hours ago
Hey — u sold ur shares u said .
Move ur ass on down the road . Nobody wants to hear you . U did what you wanted to do, now move on little man .
🎯 2 🏆️ 2 👍️ 9
attilathehunt attilathehunt 8 hours ago
WHOA!!!

3.65
Time to back up the truck....Better yet, let's back up the Santa Fe Train...and with 4 diesel engines pulling!

Surely a 4 engine locomotive can pull this dead animal out of the abyss.
🆖 1 🍼 1 🐀 1 👎️ 2 👺 1 💩 2 💸 1
attilathehunt attilathehunt 8 hours ago
And don't forget the $1,249 share price!

More like 1.249...This will be trading 4 digits to the right of the decimal very soon...

Oops...I'm begining to sound like Chris using the words "very soon". What has gotten into me?


I got to step away for a bit...My sides are killing me!


Laughter is good...but not this much!
🆖 1 🍼 1 🐀 1 👍️ 1 👎️ 1 👺 1 💩 1 😟 1 🤡 1
georgejjl georgejjl 8 hours ago
The market for blarcamesine's Alzheimer's disease treatment

Alzheimer’s Disease (AD)
In the USA ~6,900,000
In the EU (Europe) ~7,800,000
In Asia ~23,000,000
The global market ~35,000,000

https://www.anavex.com/_files/ugd/850d88_80ed72201c1f4173a87f87a09470aa46.pdf

Good luck and GOD bless,
🆖 1 👍️ 1 💩 3 🤡 2
poguemahone poguemahone 8 hours ago
George:

I believe in Santa Claus, the Easter Bunny, and unicorns!
🎯 2 🏆️ 1 🐀 1 👍️ 2 👎️ 2 👺 2 💩 2
georgejjl georgejjl 8 hours ago
I believe that the cost of Anavex's blarcamesine could start at $16 per pill and over time could be incrementally reduces to about $1.25 per pill while continuing to make a acceptable profit.

Good luck and GOD bless,
🆖 1 💩 4 🤡 3
attilathehunt attilathehunt 8 hours ago
Not...I love the free entertainment!!


Best laughs around!!!

How can you not laugh after where we are after 10 years?


Where is the PD data?....
Where is the AD data?
How many touted ex FDA'ers were hired to save the day?
Why did Chris sell?
How much dilution is still occurring?
Where is the mystery disease?
All talk on submission...SO where is it?
Why is Chris still with the company?
Why are ALL presentations met with selloffs?

3.60 share price looks like a GREAT buy until it breaks the 2's....


Way too funny!!!!
🆖 1 🍼 1 🐀 1 👍️ 1 👎️ 1 👺 1 💩 3
kund kund 8 hours ago
I heard Misleading started talking on the subway, he was talking about millions and millions of page, and entire crowd got down next station, he had entire train for himself.
🐀 1 👍️ 1 👎️ 1 👺 1 💩 2
poguemahone poguemahone 8 hours ago
I HOPE YOU ARE AS EXCITED AS WE ARE!!

Yes, that DM quote will go down in Anavex history! Are we leveraging the Partex AI Partnership? It has been 8 months of crickets on that PR. How is the PDD & ALZ data readouts going? How about the undisclosed rare disease?

What a train wreck this has all become.
🎯 1 🏆️ 1 🐀 1 👍️ 3 👎️ 1 👺 1 💩 2
Thehubby Thehubby 8 hours ago
So you have nothing better to do than come tell a bunch of strangers "I told you so"?
🆖 1 🍼 1 👍️ 4 👏 2
poguemahone poguemahone 8 hours ago
Missling is also unsure how to mail this 1 million page submission. He is trying to negotiate a reasonable delivery charge, and will consider the Pony Express (ve vill need a lot uv ponies) if USPS or FedEx plays hardball.
🎯 1 🏆️ 1 🐀 1 👍️ 1 👎️ 2 👺 2 💩 2
attilathehunt attilathehunt 8 hours ago
George, your numbers may be right on the money,


Be careful agreeing with him...He is a known trader, a big short and fabricates on everything....
Discussing revenue at this juncture, is like saying who will be President in the year 2525?

This board is becoming way too funny...At least laughter is good for you so keep them coming!!
🌋 1 🎯 1 🏆️ 1 🐀 1 👍️ 4 👎️ 1 👺 1 💩 1 💯 1 🦨 1
poguemahone poguemahone 9 hours ago
Reports are the printers keep jamming when Missling is trying to print out the 1 million pages.

In order to save the company money, Dr. Missling has made the executive decision to only use 500K sheets and print them double-sided. However, this seems to be causing more paper jams.

The filing is no longer very soon, it’s now been revised to soon or “whenever we finish printing it out.”
🎯 1 🏆️ 1 🐀 1 👍️ 4 👎️ 1 👺 1 💩 1
attilathehunt attilathehunt 9 hours ago
I believe that once Blarcamesine is approved


LOL!!!! When will that be?

I can't believe how many are still delustional...

Once I accepted defeat and sold out, it is amazing how much WGT fog has cleared up.

I keep coming back for the entertainment! I did have empathy for those still long...Not anymore...One can only say "I TOLD YOU SO" so many times before the empathy wears off and now long upon those remaining as suckers.

Unfortunately Kund was right all along!

Take this to heart....A fool and his money are soon departed....Missling sold...I wonder why?????

The meaning of the phrase "a fool and his money are soon parted" means that people with no financial literacy will generally unintentionally throw away any fortune that comes their way. Typically, the phrase does refer to money and the person's economic sense.
🎯 2 🏆️ 1 🐀 1 👍️ 1 👎️ 2 👺 3 💩 2 ☹️ 1
Investor2014 Investor2014 9 hours ago
Oh oh! Did Missling speak again somewhere?
🐀 1 👎️ 1 👺 1 💩 2 🤡 3

Your Recent History

Delayed Upgrade Clock